Robert Gibbons to Dengue Vaccines
This is a "connection" page, showing publications Robert Gibbons has written about Dengue Vaccines.
Connection Strength
0.609
-
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions. Hum Vaccin Immunother. 2019; 15(9):2090-2105.
Score: 0.176
-
Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children. Am J Trop Med Hyg. 2016 06 01; 94(6):1348-1358.
Score: 0.142
-
Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial. Am J Trop Med Hyg. 2014 Jul; 91(1):119-28.
Score: 0.125
-
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate. J Infect Dis. 2011 Aug 01; 204(3):442-50.
Score: 0.103
-
Dengue viruses cluster antigenically but not as discrete serotypes. Science. 2015 Sep 18; 349(6254):1338-43.
Score: 0.034
-
Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: a case of opposing trends. Am J Trop Med Hyg. 2013 Apr; 88(4):677-80.
Score: 0.029